Literature DB >> 32236562

Treating COVID-19 with Chloroquine.

Mingxing Huang1,2, Tiantian Tang3,4, Pengfei Pang2,5, Man Li2,6, Ruolan Ma7,8, Jiahui Lu1, Jingxian Shu9, Yingying You10, Binghui Chen11, Jiabi Liang9, Zhongsi Hong1, Huili Chen1, Ling Kong12, Dajiang Qin12,7, Duanqing Pei12,7, Jinyu Xia1, Shanping Jiang3,4, Hong Shan2,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32236562      PMCID： PMC7232130          DOI： 10.1093/jmcb/mjaa014

Source DB:  PubMed          Journal:  J Mol Cell Biol        ISSN： 1759-4685            Impact factor:   6.216


× No keyword cloud information.
  9 in total

1.  Chloroquine inhibits endosomal viral RNA release and autophagy-dependent viral replication and effectively prevents maternal to fetal transmission of Zika virus.

Authors:  Shengnan Zhang; Changhua Yi; Chufang Li; Fan Zhang; Jiaojiao Peng; Qian Wang; Xinglong Liu; Xianmiao Ye; Pingchao Li; Min Wu; Qihong Yan; Wenjing Guo; Xuefeng Niu; Liqiang Feng; Weiqi Pan; Ling Chen; Linbing Qu
Journal:  Antiviral Res       Date:  2019-06-26       Impact factor: 5.970

2.  Chloroquine, an Endocytosis Blocking Agent, Inhibits Zika Virus Infection in Different Cell Models.

Authors:  Rodrigo Delvecchio; Luiza M Higa; Paula Pezzuto; Ana Luiza Valadão; Patrícia P Garcez; Fábio L Monteiro; Erick C Loiola; André A Dias; Fábio J M Silva; Matthew T Aliota; Elizabeth A Caine; Jorge E Osorio; Maria Bellio; David H O'Connor; Stevens Rehen; Renato Santana de Aguiar; Andrea Savarino; Loraine Campanati; Amilcar Tanuri
Journal:  Viruses       Date:  2016-11-29       Impact factor: 5.048

3.  A pneumonia outbreak associated with a new coronavirus of probable bat origin.

Authors:  Peng Zhou; Xing-Lou Yang; Xian-Guang Wang; Ben Hu; Lei Zhang; Wei Zhang; Hao-Rui Si; Yan Zhu; Bei Li; Chao-Lin Huang; Hui-Dong Chen; Jing Chen; Yun Luo; Hua Guo; Ren-Di Jiang; Mei-Qin Liu; Ying Chen; Xu-Rui Shen; Xi Wang; Xiao-Shuang Zheng; Kai Zhao; Quan-Jiao Chen; Fei Deng; Lin-Lin Liu; Bing Yan; Fa-Xian Zhan; Yan-Yi Wang; Geng-Fu Xiao; Zheng-Li Shi
Journal:  Nature       Date:  2020-02-03       Impact factor: 69.504

4.  New insights into the antiviral effects of chloroquine.

Authors:  Andrea Savarino; Livia Di Trani; Isabella Donatelli; Roberto Cauda; Antonio Cassone
Journal:  Lancet Infect Dis       Date:  2006-02       Impact factor: 25.071

5.  In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine.

Authors:  Els Keyaerts; Leen Vijgen; Piet Maes; Johan Neyts; Marc Van Ranst
Journal:  Biochem Biophys Res Commun       Date:  2004-10-08       Impact factor: 3.575

6.  Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro.

Authors:  Manli Wang; Ruiyuan Cao; Leike Zhang; Xinglou Yang; Jia Liu; Mingyue Xu; Zhengli Shi; Zhihong Hu; Wu Zhong; Gengfu Xiao
Journal:  Cell Res       Date:  2020-02-04       Impact factor: 25.617

7.  A Novel Coronavirus from Patients with Pneumonia in China, 2019.

Authors:  Na Zhu; Dingyu Zhang; Wenling Wang; Xingwang Li; Bo Yang; Jingdong Song; Xiang Zhao; Baoying Huang; Weifeng Shi; Roujian Lu; Peihua Niu; Faxian Zhan; Xuejun Ma; Dayan Wang; Wenbo Xu; Guizhen Wu; George F Gao; Wenjie Tan
Journal:  N Engl J Med       Date:  2020-01-24       Impact factor: 91.245

8.  Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle.

Authors:  Hongzhou Lu; Charles W Stratton; Yi-Wei Tang
Journal:  J Med Virol       Date:  2020-02-12       Impact factor: 2.327

9.  Inhibition of human coronavirus 229E infection in human epithelial lung cells (L132) by chloroquine: involvement of p38 MAPK and ERK.

Authors:  Masakazu Kono; Koichiro Tatsumi; Alberto M Imai; Kengo Saito; Takayuki Kuriyama; Hiroshi Shirasawa
Journal:  Antiviral Res       Date:  2007-11-20       Impact factor: 5.970
  9 in total
  90 in total

Review 1.  Medication use during COVID-19: Review of recent evidence.

Authors:  T S Brandon Ng; Kori Leblanc; Darwin F Yeung; Teresa S M Tsang
Journal:  Can Fam Physician       Date:  2021-03       Impact factor: 3.275

Review 2.  Efficacy and safety of chloroquine and hydroxychloroquine for treatment of COVID-19 patients-a systematic review and meta-analysis of randomized controlled trials.

Authors:  Paul Eze; Kenechukwu N Mezue; Chidozie U Nduka; Ijeoma Obianyo; Obiora Egbuche
Journal:  Am J Cardiovasc Dis       Date:  2021-02-15

Review 3. 

Authors:  T S Brandon Ng; Kori Leblanc; Darwin F Yeung; Teresa S M Tsang
Journal:  Can Fam Physician       Date:  2021-03       Impact factor: 3.275

Review 4.  Modalities and Mechanisms of Treatment for Coronavirus Disease 2019.

Authors:  Zhihong Zuo; Ting Wu; Liangyu Pan; Chenzhe Zuo; Yingchuo Hu; Xuan Luo; Liping Jiang; Zanxian Xia; Xiaojuan Xiao; Jing Liu; Mao Ye; Meichun Deng
Journal:  Front Pharmacol       Date:  2021-02-08       Impact factor: 5.810

Review 5.  Therapeutic strategies to fight COVID-19: Which is the status artis?

Authors:  Cristina Scavone; Annamaria Mascolo; Concetta Rafaniello; Liberata Sportiello; Ugo Trama; Alice Zoccoli; Francesca Futura Bernardi; Giorgio Racagni; Liberato Berrino; Giuseppe Castaldo; Enrico Coscioni; Francesco Rossi; Annalisa Capuano
Journal:  Br J Pharmacol       Date:  2021-05-07       Impact factor: 9.473

6.  Interleukin-6 blocking agents for treating COVID-19: a living systematic review.

Authors:  Lina Ghosn; Anna Chaimani; Theodoros Evrenoglou; Mauricia Davidson; Carolina Graña; Christine Schmucker; Claudia Bollig; Nicholas Henschke; Yanina Sguassero; Camilla Hansen Nejstgaard; Sonia Menon; Thu Van Nguyen; Gabriel Ferrand; Philipp Kapp; Carolina Riveros; Camila Ávila; Declan Devane; Joerg J Meerpohl; Gabriel Rada; Asbjørn Hróbjartsson; Giacomo Grasselli; David Tovey; Philippe Ravaud; Isabelle Boutron
Journal:  Cochrane Database Syst Rev       Date:  2021-03-18

7.  Update I. A systematic review on the efficacy and safety of chloroquine/hydroxychloroquine for COVID-19.

Authors:  Andrea Cortegiani; Mariachiara Ippolito; Giulia Ingoglia; Pasquale Iozzo; Antonino Giarratano; Sharon Einav
Journal:  J Crit Care       Date:  2020-07-11       Impact factor: 3.425

Review 8.  COVID-19 drug repurposing: A review of computational screening methods, clinical trials, and protein interaction assays.

Authors:  Xueqing Wang; Yuanfang Guan
Journal:  Med Res Rev       Date:  2020-08-30       Impact factor: 12.944

Review 9.  Systematic review and meta-analysis of efficacy and safety of hydroxychloroquine and chloroquine in the treatment of COVID-19.

Authors:  Niti Mittal; Rakesh Mittal; M C Gupta; Jyoti Kaushal; Ankita Chugh; Daisy Khera; Surjit Singh
Journal:  J Family Med Prim Care       Date:  2021-07-02

10.  Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19.

Authors:  Bhagteshwar Singh; Hannah Ryan; Tamara Kredo; Marty Chaplin; Tom Fletcher
Journal:  Cochrane Database Syst Rev       Date:  2021-02-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.